An Efficacy Study of Trabectedin in the Treatment of Participants With Specific Subtypes of Metastatic Breast Cancer

NCT00580112 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
127
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Collaborators